Ryan. This patented technology pertains to biosensors, such as those found in medication discovery. Completion isdue 2016 inearly. Theexpandedfacility willprovide acentral, state-of-the-arttechnicalresourcefor our businessesinthe US, creating the important mass for effective R&D to effectively support our customers, saidAidanMernin, RD&I Director forProtectiveCoatings. Theexpanded facilitywillbe able to home up to 35 laboratory staff, with30experienced technologistsemployed primarily.Keycapabilitieswill includeadedicatedarea for experimental color making, a modern paint software laboratory and controlled drying areas for conditioning of check panels environmentally.The Potamkin Award is an excellent honor for our entire team, which is normally striving to develop options for reversing or preventing memory impairment, said the researchers. The Potamkin Prize is manufactured feasible by the philanthropic contributions of the Potamkin category of New York, Philadelphia and Miami. The goal of the prize is definitely to help attract the best medical minds & most dedicated scientists in the world to the field of dementia study. The Potamkin family offers been the Academy’s single largest individual donor since 1988, providing a lot more than $2 million to fund the Potamkin Prize.. $8.4 million research grant to boost patient safety in Australia A significant cross institutional study collaboration targeted at reducing the amount of individuals harmed in Australia has received $8.4 million in funding in the latest round of National Health insurance and Medical Analysis Council system grants.